VEGFR2 Inhibitors [MoA]

Known as: VEGFR2 Inhibitors 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2009-2017
012320092017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Vascular endothelial growth factor receptor 2 (VEGFR2) has been proven to play a major role in the regulation of tumor… (More)
Is this relevant?
2016
2016
Antiangiogenic tyrosine kinase inhibitors (TKI) that target VEGF receptor-2 (VEGFR2) have not been effective as adjuvant… (More)
Is this relevant?
Review
2015
Review
2015
During the past decade, developments in computational processing and X-ray crystallography have allowed virtual screening become… (More)
Is this relevant?
Review
2015
Review
2015
The introduction of small-molecule tyrosine kinase VEGFR2 (vascular endothelial growth factor receptor) inhibitors has added… (More)
Is this relevant?
2015
2015
VEGFR2 has been proved to play a major role in the regulation of tumor angiogenesis. Twenty-one 4-alkoxyquinazoline-based… (More)
  • figure 2
  • table 2
  • table 1
  • figure 3
  • table 3
Is this relevant?
2010
2010
BACKGROUND Hypertension (HT) and hand-foot skin reactions (HFSR) may be related to the activity of bevacizumab and sorafenib. We… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
2009
2009
PURPOSE Bv8, also known as prokineticin 2, has been recently shown to be a mediator of myeloid cell-dependent tumor angiogenesis… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?